2025 HCPCS Code J9021
Injection, asparaginase, recombinant, (rylaze), 0.1 mg
| Short Description | Inj, aspara, rylaze, 0.1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2022 |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J2060 - Lorazepam injection
- J2062 - Loxapine for inhalation 1 mg
- J2150 - Mannitol injection
- J2151 - Inj, mannitol, 250 mg
- J2170 - Mecasermin injection
- J2175 - Meperidine hydrochl /100 mg
- J2180 - Meperidine/promethazine inj
- J2182 - Injection, mepolizumab, 1mg
- J2183 - Inj meropenem (wg crit care)
- J2184 - Inj, meropenem (b. braun)
- J2185 - Meropenem
- J2186 - Inj., meropenem, vaborbactam
- J2210 - Methylergonovin maleate inj
- J2212 - Methylnaltrexone injection
- J2246 - Inj, micafungin (baxter)
- J2247 - Inj, micafungin (par pharm)
- J2248 - Micafungin sodium injection
- J2249 - Inj, remimazolam, 1 mg
- J2250 - Inj midazolam hydrochloride
- J2251 - Inj midazolam in 0.9% nacl